Incyte Corporation (INCY) News Headlines

▮ More

Date

Headline

3/20/2023 4:08:49 PM William Blair Reiterates Incyte Corporation (INCY) At Outperform

3/7/2023 6:31:47 AM Caris Life Sciences, Incyte Enter Broad Precision Medicine Partnership To Advance Incyte's Oncology Pipeline

2/28/2023 3:45:54 AM Biotech Stocks Facing FDA Decision In March 2023

2/7/2023 7:16:15 AM Incyte Corporation Q4 Profit Decreases, but beats estimates

2/7/2023 7:07:23 AM Incyte Q4 GAAP EPS $0.13; Non-GAAP EPS $0.62

12/5/2022 7:10:18 AM Syndax Pharma, Incyte Publish Axatilimab Phase 1/2 Data In Patients With Chronic Graft-Versus-Host Disease

11/1/2022 7:37:22 AM Incyte Corporation Q3 Profit Decreases, misses estimates

11/1/2022 7:09:06 AM Incyte Q3 GAAP EPS $0.50; Non-GAAP EPS $0.60

11/1/2022 7:00:06 AM Incyte Q3 22 Earnings Conference Call AT 8:00 AM ET

9/12/2022 11:30:03 AM Incyte To Present At Morgan Stanley Healthcare Conference; Webcast At 12:30 PM ET

8/26/2022 10:16:14 AM Incyte : FDA Oks Pemazyre For Treatment Of Myeloid/lymphoid Neoplasms With FGFR1 Rearrangement

8/26/2022 10:02:40 AM Incyte : FDA Approves Pemazyre As Targeted Treatment For Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

8/2/2022 7:25:58 AM Incyte Q1 Results Top Estimates

8/2/2022 7:09:50 AM Incyte Q2 GAAP EPS $0.72; Non-GAAP EPS $1.01

8/2/2022 7:00:23 AM Incyte Q2 22 Earnings Conference Call At 8:00 AM ET

6/28/2022 3:17:30 AM Biotech Stocks Facing FDA Decision In July 2022

6/15/2022 6:55:15 AM Pre-market Movers: REV, ASTL, VNRX, VORB, GGR…

6/14/2022 10:00:59 AM Incyte To Present At Goldman Sachs Global Healthcare Conference; Webcast At 11:00 AM ET

6/14/2022 3:39:14 AM FDA Approves First Medicine Ever For Alopecia Areata

6/14/2022 1:47:24 AM FDA Approves Lilly's Olumiant As First Systemic Treatment For Alopecia